Advanced Cancer
This study is a multicenter, open-label, dose-escalation phase 1 study of intravenous (IV) LY2495655 in participants with advanced cancer.
AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.
Free account
You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.